Literature DB >> 2979248

Prophylaxis of aspirin-induced gastric mucosal bleeding with ranitidine.

C J Hawkey1, K W Somerville, S Marshall.   

Abstract

The ability of ranitidine to protect the human gastric mucosa against aspirin-induced damage was investigated by timed measurements of blood loss collected by gastric washing. Ranitidine (150 mg) 1 h or 5 h before 900 mg aspirin (5 doses of each) over 48 h reduced subsequent mean bleeding from 7.7 microliters/10 min to 2.6 microliters/10 min or 3.4 microliters/10 min, respectively. Both regimens were antisecretory at the time of aspirin administration, as judged by a rise in the pH of the aspirated washings. The prolonged protection against aspirin-induced bleeding achieved with twice daily dosing with ranitidine has clinical potential in the management of patients taking anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2979248     DOI: 10.1111/j.1365-2036.1988.tb00694.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans.

Authors:  N Hudson; F E Murray; A T Cole; B Filipowicz; C J Hawkey
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Recognition and treatment of unstable angina.

Authors:  C Brunelli; P Spallarossa; P Rossettin; S Caponnetto
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

3.  Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.

Authors:  T K Daneshmend; A G Stein; N K Bhaskar; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.

Authors:  G K Kitchingman; P J Prichard; T K Daneshmend; R P Walt; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 6.  Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract.

Authors:  Martin W James; Christopher J Hawkey
Journal:  Br J Clin Pharmacol       Date:  2003-08       Impact factor: 4.335

7.  Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements.

Authors:  T R Madhusudhan; A Rangan; P J Gregg
Journal:  Ann R Coll Surg Engl       Date:  2008-05       Impact factor: 1.891

8.  Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.

Authors:  P J Prichard; G K Kitchingman; R P Walt; T K Daneshmend; C J Hawkey
Journal:  BMJ       Date:  1989-02-25

9.  Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.

Authors:  M G Robinson; J W Griffin; J Bowers; F J Kogan; D G Kogut; F L Lanza; C W Warner
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.